Table 3.
Demographic and clinical characteristics of study participants by treatment* experience
| Patient characteristics | All (n = 120) | Completed (n = 30) | Discontinued (n = 30) | Current (n = 30) | Naïve (n = 30) |
|---|---|---|---|---|---|
| Age in years, mean(±SD) |
49.1 (±11.6) |
56.8 (±8.4) |
49.9 (±9.6) |
47.6 (±9.7) |
42.0 (±13.2) |
| Male, n (%) |
67 (56) |
17 (57) |
16 (53) |
17 (57) |
17 (57) |
| Married, n (%) |
29 (24) |
11 (37) |
8 (27) |
7 (23) |
3 (10) |
| Living alone at time of treatment, n (%)a |
34 (38) |
12 (40) |
10 (33) |
12 (40) |
NA |
|
Race/ethnicity, n (%)b | |||||
| Caucasian/White |
76 (63) |
25 (83) |
16 (53) |
22 (73) |
13 (43) |
| African American/Black |
28 (23) |
3 (10) |
8 (27) |
6 (20) |
11 (37) |
| Hispanic/Latino |
12 (10) |
2 (7) |
5 (17) |
1 (3) |
4 (13) |
| Asian/Native Hawaiian/Other Pacific Islander |
3 (3) |
0 (0) |
1 (3) |
1 (3) |
1 (3) |
| American Indian/Alaskan Native |
1 (1) |
0 (0) |
0 (0) |
1 (3) |
0 (0) |
| Other |
1 (1) |
0 (0) |
0 (0) |
0 (0) |
1 (3) |
|
Highest education level, n (%)b | |||||
| Bachelors/graduate degree |
28 (23) |
11 (37) |
8 (27) |
6 (20) |
3 (10) |
| Some college/2 year associate degree |
50 (42) |
11 (37) |
13 (43) |
13 (43) |
13 (43) |
| High school diploma/GED |
32 (27) |
7 (23) |
7 (23) |
10 (33) |
8 (27) |
| Less than high school |
10 (8) |
1 (3) |
1 (7) |
1 (3) |
6 (20) |
|
Health insurance status when deciding whether to start treatment , n(%)c | |||||
| Private |
61 (51) |
19 (63) |
19 (63) |
13 (43) |
10 (33) |
| No health insurance |
26 (22) |
4 (13) |
4 (13) |
9 (30) |
9 (30) |
| Medicaid only |
19 (16) |
3 (10) |
6 (20) |
5 (17) |
5 (17) |
| Medicare or Medicaid/Medicare dual |
9 (8) |
2 (7) |
1 (3) |
1 (3) |
5 (17) |
| Military insurance/TRICARE/VA |
5 (4) |
2 (7) |
0 (0) |
2 (7) |
1 (3) |
|
Comorbid conditions, n (%)d | |||||
| Depression |
62 (52) |
10 (33) |
16 (53) |
19 (63) |
17 (57) |
| Anxiety |
53 (44) |
9 (30) |
11 (37) |
15 (50) |
18 (60) |
| Compensated cirrhosis |
18 (15) |
5 (17) |
8 (27) |
4 (13) |
1 (3) |
| Diabetes |
9 (8) |
3 (10) |
4 (13) |
1 (3) |
1 (3) |
| Time since HCV diagnosis in years, mean (±SD) | 7.3 (±5.7) | 10.4 (±6.4) | 9.1 (±5.0) | 5.4 (±5.5) | 4.2 (±3.2) |
*Treatment refers to pegylated interferon and ribavirin (PR).
aLiving alone at the time of treatment was not assessed for the treatment-naïve population, therefore the total denominator for all patients = 90.
bPercentages may not add to 100% because of rounding.
cCurrent health insurance status (i.e., status at the time of the interview) is captured for treatment-naïve patients.
dPatients may have more than one comorbid condition.